%0 Journal Article
%K Female
%K Humans
%K Aged
%K Male
%K Middle Aged
%K Time Factors
%K ADAM Proteins/genetics/metabolism
%K Administration, Oral
%K Amyloid Precursor Protein Secretases/genetics/metabolism
%K Amyloid beta-Peptides/metabolism
%K Animals
%K Brain/drug effects/pathology/physiopathology
%K Cognition/drug effects
%K Cytokines/metabolism
%K Dementia/blood/ pathology/physiopathology
%K Gliosis/metabolism/pathology/physiopathology
%K Glycosylation End Products, Advanced/administration & dosage/ adverse
%K effects/toxicity
%K Insulin/pharmacology
%K Membrane Proteins/genetics/metabolism
%K Memory/drug effects
%K Metabolic Syndrome X/blood/ pathology/physiopathology
%K Mice
%K Mice, Inbred C57BL
%K Nicotinamide Phosphoribosyltransferase/metabolism
%K Oxidative Stress/drug effects
%K PPAR gamma/metabolism
%K Pyruvaldehyde/administration & dosage/ adverse effects/blood/toxicity
%K Receptors, Immunologic/metabolism
%K Sirtuin 1/antagonists & inhibitors/metabolism
%K Transcription, Genetic/drug effects
%B Proceedings of the National Academy of Sciences of the United States of America
%D 2014
%F PROF
%G eng
%M 24567379
%P 4940-5
%T Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans
%V 111
%2 PMC3977256
%7 2014/02/26
%@ 1091-6490 (Electronic)<br/>0027-8424 (Linking)